Absci Investor Presentation Deck

BIOTECH INDUSTRY INFLECTION POINT Absci is solving the problem of scalable biological data enabling true generative Al for biologics drug discovery Absci's E.coli SoluPro™ cell line Billions of cells, expressing proteins of interest ABSCI CORPORATION 2023 ALL RIGHTS RESERVED Absci's ACE Assay™ screens billions of unique drug variant candidates 2009 29999 0.000 200000 00000 ●●●●● NON-BINDING . TIGHT BINDING High-quality data flows into Absci's generative Al engine ai absci. 6

View entire presentation